Skip to main navigation Skip to search Skip to main content

Awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) in 4 major cities in the United States

  • Jeffrey V. Lazarus
  • , Trenton M. White
  • , Alina M. Allen
  • , Silvana Pannain
  • , Naim Alkhouri
  • , Meena B. Bansal
  • , Michael Charlton
  • , Brett E. Fortune
  • , Yehuda Handelsman
  • , Scott Isaacs
  • , Ira M. Jacobson
  • , Sonal Kumar
  • , Melina I. Manolas
  • , Mazen Noureddin
  • , Mary E. Rinella
  • , Norah Terrault
  • , Ayman El-Mohandes

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Article number10.1097/HC9.0000000000000704
JournalHepatology Communications
Volume9
Issue number5
DOIs
StatePublished - May 6 2025
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • MASH
  • MASLD
  • diabetes
  • noncommunicable diseases
  • prevention
  • risk factors
  • urban health policy

ASJC Scopus subject areas

  • Hepatology

Cite this